XML 26 R8.htm IDEA: XBRL DOCUMENT v3.6.0.2
Condensed Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Cash flows from operating activities:      
Net income $ 121,274,000 $ 113,655,000 $ 112,629,000
Adjustments to reconcile net income to net cash provided by operating activities:      
Stock-based compensation 19,509,000 18,698,000 19,260,000
Tax benefit from stock based compensation 0 (10,510,000) (2,978,000)
Depreciation and amortization 21,102,000 20,757,000 15,077,000
Loss on disposal of fixed assets 652,000 1,780,000 291,000
Goodwill, Impairment Loss 0 3,045,000 0
Deferred taxes (6,588,000) 7,271,000 4,583,000
Accrued interest on note receivable – related party (63) (71) (156)
Increase (Decrease) in Accrued Interest Receivable, Net 63,000 71,000 156,000
Repayment of Notes Receivable from Related Parties 409,000 409,000 409,000
Deferred rent expense 2,565,000 440,000 2,769,000
Loss (gain) on sale of marketable securities 661,000 (67,000) (677,000)
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability (425,000) (5,576,000) (2,139,000)
Changes in:      
Accounts receivable (13,617,000) (11,071,000) (144,000)
Due from factor 11,043,000 7,281,000 3,734,000
Inventories (17,744,000) (9,403,000) (1,841,000)
Prepaid expenses, prepaid taxes, deposits and other (3,461,000) 4,784,000 (294,000)
Accounts payable and accrued expenses 15,324,000 (8,643,000) 3,777,000
Accrued incentive compensation 1,819,000 468,000 (1,910,000)
Other liabilities 1,144,000 2,716,000 (61,000)
Net cash provided by operating activities 153,604,000 135,963,000 152,329,000
Cash flows from investing activities:      
Purchases of property and equipment (15,897,000) (19,459,000) (18,341,000)
Purchases of marketable securities (40,451,000) (48,891,000) (137,348,000)
Proceeds from Collection of Notes Receivable 249,000 466,000 893,000
Maturity/sale of marketable securities 52,215,000 43,353,000 128,663,000
Acquisitions 0 (9,129,000) (81,885,000)
Net cash used in investing activities (3,884,000) (33,660,000) (108,018,000)
Cash flows from financing activities:      
Proceeds from exercise of stock options 10,713,000 21,301,000 4,943,000
Payments to Acquire Businesses, Gross (3,759,000)    
Tax benefit from the exercise of options 0 10,510,000 2,978,000
business combinations contingent liability payment (16,402,000) (6,270,000) (8,475,000)
Common stock purchased for treasury (86,005,000) (135,637,000) (142,228,000)
Net cash provided by financing activities (95,453,000) (110,096,000) (142,782,000)
Effect of Exchange Rate on Cash and Cash Equivalents (566,000) (1,243,000) (354,000)
Net decrease in cash and cash equivalents 53,701,000 (9,036,000) (98,825,000)
Cash and cash equivalents – beginning of period 72,414,000 81,450,000 180,275,000
Cash and cash equivalents – end of period 126,115,000 72,414,000 81,450,000
Cash paid during the year for:      
Interest 520,000 469,000 211,000
Income taxes $ 55,384,000 $ 39,424,000 $ 49,829,000